A University of Ala.
gynecologist says he might be the first oncologists to use artificial in vitro fertilization.
Dr. Chris Furlong, a gynecogenist at the University of Birmingham, said the idea has been in the works for several years and that he is currently the first UAB doctor to use it.
He told ABC News he had been considering the possibility for years and it was something he was excited about.
Furlong said he is not concerned about the ethics of artificial IVF and that there is no need to do anything unethical.
Fertility experts said there is still a long way to go before artificial inbreeding becomes routine, but that the potential is significant.
Fidelity and surrogacy experts told ABC that there are a number of issues that need to be addressed before the technology becomes widespread.
They pointed to the ethical issues surrounding artificial inking.
The technique involves using a syringe to inject an egg into a surrogate and then inserting the surrogate’s sperm into a donor egg.
While it may be ethical, surrogacy providers are concerned about what would happen if the surrogate becomes infertile and needs IVF treatment.
They also fear that artificial in-vitro fertilization could cause genetic disorders such as cystic fibrosis.
A report released this month by the American College of Obstetricians and Gynecologists said that the technology is still in its infancy and that the benefits and risks of IVF are still being studied.
In an email, Dr. William D. Johnson, an assistant professor of obstetrics and gynecologists at the university, said, “It is true that IVF is a highly experimental technology and is not yet ready for widespread use.
However, in the coming years, the potential for future fertility advances in IVF may become more clear.
If this happens, it will be crucial to evaluate the safety and efficacy of these technologies as we learn more about their potential for treating infertility and pregnancy problems.”